Novel reagents for bioconjugation improve selectivity and stability in protein modification, highlighting clinical applications.
Site selective protein modification is a vital tool in chemical biology and associated biomedical research. In this manuscript, simple, easy-to-prepare acryloyl imides are revealed as novel reagents for selective N-terminal protein bioconjugation, using conjugate addition/ring expansion (CARE) cascade reactions. Advantages of the CARE approach include high selectivity for N-terminal modification over lysine side chains, the formation of stable bioconjugates driven by irreversible ring expansion, and the ability to generate proteins modified with relatively complex, functionalized macrocycles. The selective N-terminal modification of a series of medicinally relevant proteins is demonstrated, allowing the imaging of prostate cancer tissue slices and the modulation of cell surface chemokine receptors.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: